Human Molecular Genetics Advance Access originally published online on November 17, 2005
Human Molecular Genetics 2005 14(24):3847-3855; doi:10.1093/hmg/ddi409
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular complementation of IL-12Rß1 deficiency reveals functional differences between IL-12Rß1 alleles including partial IL-12Rß1 deficiency


1Department of Infectious Diseases and 2Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, C5-38, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
* To whom correspondence should be addressed. Tel: +31 715261784/2613; Fax: +31 715266758; Email: e.van_de_vosse{at}lumc.nl
Received September 8, 2005; Accepted October 26, 2005
Patients with mutations in IL12RB1, the gene encoding IL-12Rß1, suffer from combined IL-12R/IL-23R deficiency and are unusually susceptible to nontuberculous mycobacteria and salmonellae. The functional effects of amino acid changes in IL-12Rß1, however, have not been determined at the molecular level. Molecular complementation studies are essential to demonstrate how structural amino acid changes affect IL-12Rß1 function, and whether functionally different IL-12Rß1 alleles can be distinguished. Thirteen different IL-12Rß1 alleles, including 11 amino acid substitutions and the two major haplotypes (214Q-365M-378G and 214R-365T-378R), were retrovirally transduced in IL-12Rß1 deficient human T cells. We provide functional evidence that L77P, R173P, C186S, R213W and Y367C are deleterious mutations leading to non-functional proteins. Conversely, S74R, R156H, H438Y, A525T and G594E are fully functional IL-12Rß1 variants. The C198R mutation leads to a partially functional IL-12Rß1, representing the first molecularly proven partial IL-12Rß1 deficiency. Interleukin-12 (IL-12) induced not only Interferon-
but also IL-10 in all responder but not in null-mutant alleles, with intermediate levels in C198R. The QMG allele was found to be a higher IL-12 responder allele compared with the RTR allele. These results have implications for understanding IL-12R/IL-23R structure-function and the role of IL-12R/IL-23R in human disease.
Shared senior authorship.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. van de Vosse, E. M. Verhard, R. A. de Paus, G. J. Platenburg, J. C. T. van Deutekom, A. Aartsma-Rus, and J. T. van Dissel Antisense-mediated exon skipping to correct IL-12R{beta}1 deficiency in T cells Blood, May 7, 2009; 113(19): 4548 - 4555. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. van de Wetering, R. A. de Paus, J. T. van Dissel, and E. van de Vosse IL-23 modulates CD56+/CD3- NK Cell and CD56+/CD3+ NK-like T Cell function differentially from IL-12 Int. Immunol., February 1, 2009; 21(2): 145 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sahiratmadja, B. Alisjahbana, T. de Boer, I. Adnan, A. Maya, H. Danusantoso, R. H. H. Nelwan, S. Marzuki, J. W. M. van der Meer, R. van Crevel, et al. Dynamic Changes in Pro- and Anti-Inflammatory Cytokine Profiles and Gamma Interferon Receptor Signaling Integrity Correlate with Tuberculosis Disease Activity and Response to Curative Treatment Infect. Immun., February 1, 2007; 75(2): 820 - 829. [Abstract] [Full Text] [PDF] |
||||


